Ogilvy Health's global CEO looks to help pharma reassess corporate branding amid pandemic

Pharma companies are rethinking the importance of corporate brands as the industry's work fighting COVID-19 offers an opening to boost their reputations. Kate Cronin, the newly tapped global CEO of Ogilvy Health, sees that reflected in new business briefs, with pitches now centered on reputation and societal impact.